| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 46.8% | 58/124 |
| Female | 53.2% | 66/124 |
| Indifferent | 0% | 0/124 |
| Unknown | 0% | 0/124 |
| General | ||
| 2.4% | 3/124 | |
| 0.8% | 1/124 | |
| 4.8% | 6/124 | |
| 8.1% | 10/123 | |
| 13.7% | 17/124 | |
| 42.7% | 53/124 | |
| 53.2% | 66/124 | |
| 76.6% | 95/124 | |
| 57.3% | 71/124 | |
| 85.3% | 64/75 | |
| Neurology | ||
| 64.5% | 80/124 | |
| 41.9% | 52/124 | |
| 43.5% | 54/124 | |
| Facial abnormalities | ||
| 20.2% | 25/124 | |
| 71.8% | 89/124 | |
| 37.9% | 47/124 | |
| 55.6% | 69/124 | |
| Visual and hearing impairments | ||
| 7.3% | 9/124 | |
| 49.2% | 61/124 | |
| Heart | ||
| 8.1% | 10/124 | |
| Pulmonary | ||
| 2.3% | 2/87 | |
| Gastrointestinal | ||
| 8.1% | 10/124 | |
| Urogenital | ||
| 16.1% | 20/124 | |
| Skeleton | ||
| 48.4% | 60/124 | |
| Skin / Hair / Nails | ||
| 27.4% | 34/124 | |
| Endocrine / Immunological / Metabolic | ||
| 4% | 5/124 | |
| 1.6% | 2/124 | |
| 3.2% | 4/124 | |
| Neoplasia | ||
| 0.8% | 1/124 | |
| Inheritance | ||
| 72.7% | 88/121 | |
CHD3